James E Crowe Selected Research

James E Crowe Research Topics

Disease

114	Infections 05/2024 - 04/2003
32	Human Influenza (Influenza) 01/2023 - 06/2003
22	COVID-19 05/2024 - 01/2020
19	Virus Diseases (Viral Diseases) 11/2023 - 04/2005
16	Dengue (Dengue Fever) 12/2022 - 03/2012
12	Respiratory Syncytial Virus Infections 05/2023 - 07/2003
11	Ebola Hemorrhagic Fever 01/2021 - 01/2016
9	Severe Dengue 12/2018 - 03/2012
7	Communicable Diseases (Infectious Diseases) 01/2022 - 05/2013
6	Reinfection 01/2022 - 08/2014
6	Smallpox (Variola) 07/2008 - 04/2004
5	Coinfection 01/2023 - 03/2007
5	Inflammation (Inflammations) 01/2021 - 01/2020
5	Vaccinia 10/2019 - 09/2004
4	Hantavirus Infections 01/2023 - 01/2021
4	Zika Virus Infection 10/2020 - 01/2017
4	Neoplasms (Cancer) 09/2020 - 06/2003
3	Weight Loss (Weight Reduction) 05/2020 - 01/2015
3	Convalescence 01/2019 - 04/2004
3	Acquired Immunodeficiency Syndrome (AIDS) 05/2016 - 01/2007
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2016 - 03/2004
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2023 - 01/2020
2	Breakthrough Infections 01/2022 - 07/2021
2	Persistent Infection 01/2022 - 02/2016
2	Staphylococcal Infections 11/2021 - 12/2010
2	West Nile Fever 10/2021 - 01/2019
2	Alphavirus Infections 11/2020 - 01/2018
2	Viremia 01/2019 - 06/2017
2	Arthritis (Polyarthritis) 01/2019 - 01/2017
2	Filoviridae Infections 01/2018 - 01/2018
2	HIV Infections (HIV Infection) 01/2016 - 01/2015
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2012 - 01/2010
1	Renal Insufficiency (Renal Failure) 01/2023
1	Vesicular Stomatitis 01/2022
1	Sepsis (Septicemia) 01/2022
1	Disease Progression 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Lung Diseases (Lung Disease) 12/2020
1	Coronavirus Infections 12/2020
1	Flavivirus Infections 10/2020

Drug/Important Bio-Agent (IBA)

64	AntibodiesIBA 11/2023 - 09/2008
62	Monoclonal AntibodiesIBA 05/2024 - 07/2008
54	VaccinesIBA 05/2024 - 06/2003
40	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2005
34	EpitopesIBA 01/2023 - 04/2003
31	Neutralizing AntibodiesIBA 11/2023 - 09/2008
13	Glycoproteins (Glycoprotein)IBA 04/2024 - 07/2015
13	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 03/2010
12	Broadly Neutralizing AntibodiesIBA 05/2024 - 07/2010
10	AntigensIBA 01/2023 - 04/2003
10	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2011
9	Immunoglobulin G (IgG)IBA 01/2022 - 06/2003
8	CytokinesIBA 06/2017 - 04/2004
7	Messenger RNA (mRNA)IBA 12/2022 - 08/2012
7	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2009
6	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2007
5	Neuraminidase (Sialidase)IBA 12/2019 - 10/2012
5	Polysaccharides (Glycans)IBA 01/2019 - 01/2018
4	Peptides (Polypeptides)IBA 10/2020 - 03/2007
4	Dengue VaccinesIBA 01/2019 - 06/2013
4	Blocking AntibodiesIBA 01/2018 - 03/2012
4	Fc Receptors (Fc Receptor)IBA 01/2018 - 03/2012
3	cilgavimab and tixagevimab drug combinationIBA 05/2024 - 01/2022
3	COV2-2130IBA 04/2023 - 01/2020
3	Ebola VaccinesIBA 01/2021 - 01/2019
3	Complementarity Determining Regions (Complementarity Determining Region)IBA 10/2020 - 12/2009
3	MucinsIBA 01/2019 - 05/2009
2	IronIBA 01/2019 - 12/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 03/2002
2	Immune Sera (Antisera)IBA 01/2019 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2012
2	Carrier Proteins (Binding Protein)IBA 04/2015 - 12/2010
2	InterferonsIBA 08/2012 - 04/2004
2	Viral RNAIBA 12/2010 - 05/2009
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2010 - 05/2009
2	EnzymesIBA 07/2008 - 03/2007
2	Aventis Pasteur smallpox vaccineIBA 03/2005 - 09/2004
1	2019-nCoV Vaccine mRNA-1273IBA 05/2024
1	COVID-19 VaccinesIBA 05/2024
1	AerosolsIBA 11/2023
1	Explosive Agents (Explosives)IBA 10/2023
1	Recombinant ProteinsIBA 10/2023
1	cilgavimabIBA 04/2023
1	ADM03820IBA 03/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	OMPA outer membrane proteinsIBA 01/2022
1	PorinsIBA 01/2022
1	Therapeutic UsesIBA 12/2021
1	Photosensitizing Agents (Photosensitizers)IBA 11/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Sulfates (Sulfates, Inorganic)IBA 01/2021
1	atoltivimabIBA 01/2021
1	odesivimabIBA 01/2021
1	Subgenomic RNAIBA 01/2021
1	maftivimabIBA 01/2021
1	ansuvimabIBA 01/2021

Therapy/Procedure

23	Therapeutics 01/2023 - 03/2002
2	Hematopoietic Stem Cell Transplantation 03/2012 - 01/2010
1	Nebulizers and Vaporizers (Inhaler) 12/2022